COVID-19: all 7,776 studies

Page 39 of 78. Open to participants first (483), then studies with results posted, then the rest; newest registration first within each.

• BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self TestCompletedNCT04959760Not applicable
• Acupuncture for Olfactory Dysfunction in Infected COVID-19 PatientsStatus unknownNCT04959747Not applicable
• Online Physical Therapy Management for Physiotherapists to Cope Psychological Distress During Covid-19 PandemicCompletedNCT04959708Not applicable
• COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIVCompletedNCT04958889
• Impact of Facemasks on Running During COVID-19 PandemicCompletedNCT04958863Not applicable
• Changes in Physical Activity Status: Comparison of Older Adults With Versus Without a History of Covid-19 InfectionStatus unknownNCT04958681
• Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptomsWithdrawnNCT04958161Not applicable
• Pregnant Women Vaccinated Against Covid-19.CompletedNCT04957953
• Lipid Emulsion Infusion and COVID-19 PatientsCompletedNCT04957940Phase 3
• Effect of Hand-Washing Training in Covid-19CompletedNCT04957017Not applicable
• Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU PatientsStatus unknownNCT04956913
• Cognitive Training in Survivors of Covid-19: A Randomized TrialCompletedNCT04956887Not applicable
• Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 VaccinesCompletedNCT04954651
• Musculoskeletal Problems in School Children During the COVID-19 PandemicStatus unknownNCT04954612
• Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and AdolescentsCompletedNCT04954287Phase 1
• Pilot Study for PET/MR Imaging of Covid-19TerminatedNCT04954248Not applicable
• Recovery of Respiratory System in COVID-19 PatientsCompletedNCT04954222
• A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein CannulationCompletedNCT04954118Not applicable
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19Status unknownNCT04954040Phase 2
• Immunogenicity and Safety of an Inactivated COVID-19 VaccineCompletedNCT04953325Phase 4
• Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)WithdrawnNCT04953312Not applicable
• Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19CompletedNCT04953247
• Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following DischargeCompletedNCT04953234Not applicable
• Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19Status unknownNCT04953091
• Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer PatientsCompletedNCT04953065
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.WithdrawnNCT04953052Phase 2
• Use of Saliva for COVID-19 DiagnosisCompletedNCT04953039
• Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 DiseaseCompletedNCT04952857Phase 4
• Functional Capacity in Survivors of COVID-19 Related ARDSStatus unknownNCT04952844
• Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.Status unknownNCT04952805Phase 2/3
• Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly AdultsCompletedNCT04952727Phase 4
• Efficacy of Amantadine Treatment in COVID-19 PatientsTerminatedNCT04952519Phase 3
• Equitable Access to COVID-19 VaccinesCompletedNCT04952376Not applicable
• Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCTStatus unknownNCT04952350Phase 3
• Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Status unknownNCT04952337
• A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in AdolescentsCompletedNCT04951388Phase 2
• Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.CompletedNCT04951349Phase 2
• Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)Status unknownNCT04951323Phase 3
• A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 PatientsActive, not recruitingNCT04950803Not applicable
• Covid-19 Virtual Recovery StudyCompletedNCT04950725Not applicable
• Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in PatientsStatus unknownNCT04950673
• Assessment of Vitamin D Level in COVID-19CompletedNCT04949412
• Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.Status unknownNCT04949386Phase 2
• A Retrospective Study of COVID-19 TreatmentsCompletedNCT04949230
• The Effectiveness of Culturally Adapted Cognitive Behavioral Intervention Among COVID-19 SurvivorsCompletedNCT04949061Not applicable
• Mental Status and Quality of Life of Post-COVID-19 PatientsCompletedNCT04949035
• Gene Polymorphism of IL17 and IL 23CompletedNCT04948515
• Measuring Work-Related Stress in Primary Care in the Covid-19 PandemicCompletedNCT04948255
• Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)Status unknownNCT04948242
• Canine COVID-19 Detection Phase 2 and 3Status unknownNCT04948190
• Geriatric Care for Older People Hospitalised for COVID-19CompletedNCT04947943
• COVID-19 in Nursing Homes 2020 and 2021CompletedNCT04945863
• Psychologic Impact of COVID-19 Pandemic on the Hospital Staff of the Nouvelle Aquitaine AreaStatus unknownNCT04945837Not applicable
• Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH QuettaCompletedNCT04945811Not applicable
• The VIDA After COVID StudyWithdrawnNCT04945590Not applicable
• The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 InfectionCompletedNCT04945577
• Covid-19 Patients Management During Home IsolationStatus unknownNCT04945564Not applicable
• Telerehabilitation During Pandemic Containment Measures of COVID19CompletedNCT04945356Not applicable
• Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)Status unknownNCT04944823
• Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis PatientsCompletedNCT04944433
• Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)CompletedNCT04944368Phase 2
• Breathing After COVID-19Status unknownNCT04944342
• Hip Fracture and COVID-19CompletedNCT04944329
• Cognitive Training and Brain Stimulation in Patients With Post-COVID-19 Cognitive ImpairmentCompletedNCT04944147Not applicable
• Phase 2 Study of RSLV-132 in Subjects With Long COVIDCompletedNCT04944121Phase 2
• Change in Antibody Levels Following SARS-CoV-2 (Covid-19) VaccinationsStatus unknownNCT04944095
• Remdesivir- Ivermectin Combination Therapy in Severe Covid-19Status unknownNCT04944082Phase 4
• Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac VaccineCompletedNCT04942405Phase 3
• Digital Dance for People With Parkinson's Disease During the COVID-19 PandemicCompletedNCT04942392Not applicable
• imPulse™ Una Infrasound-to-ultrasound E-stethoscopeCompletedNCT04941209
• Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 PatientsTerminatedNCT04941183Phase 1
• Long-Term Follow-up Survey of COVID-19 Vaccine After VaccinationCompletedNCT04941144
• Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19CompletedNCT04941105Phase 3
• Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICUCompletedNCT04941092
• Seroprevalence of COVID-19CompletedNCT04941053
• Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)CompletedNCT04941001Not applicable
• Chronic Pain in COVID-19 Patients Discharged From Intensive Care UnitCompletedNCT04940208
• A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19CompletedNCT04940182Phase 3
• SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral VectorActive, not recruitingNCT04939402Not applicable
• Methylation Effects of COV-19 Infection and VaccinationsStatus unknownNCT04939155
• Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular DysfunctionStatus unknownNCT04937712
• Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19CompletedNCT04937621
• Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm ParametersTerminatedNCT04937608
• Cognitive and Psychological Disorders After Severe COVID-19 InfectionCompletedNCT04937582Not applicable
• Ivermectin Versus Standard Treatment in Mild COVID-19Status unknownNCT04937569Phase 3
• Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).CompletedNCT04937556Not applicable
• Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19CompletedNCT04937543Phase 2
• Outpatient Liquid Aspirin (OLA)Status unknownNCT04937088Phase 2
• Immune Response to the COVID-19 VaccineCompletedNCT04936997Early Phase 1
• Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19CompletedNCT04936503Not applicable
• Home Based Exercises With and Without Posture and Ergonomics Training Among Students During COVID-19CompletedNCT04935502Not applicable
• Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 PandemicCompletedNCT04935489Not applicable
• Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19Status unknownNCT04935476Phase 3
• Mucormycosis in COVID-19CompletedNCT04935463
• Pulmonary Inflammation in COVID-19 ARDSStatus unknownNCT04935450
• Implementing a Rehabilitation Program in Patients Recovering From Covid-19 InfectionCompletedNCT04935437Not applicable
• Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.CompletedNCT04934215
• Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19Status unknownNCT04934111Phase 1
• COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and EducationCompletedNCT04934085
• Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid HemorrhageCompletedNCT04934020

← COVID-19 overview